CLINICAL_TRIALS
trial_result
· 2015-04-09
Clinical Trial Update: A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis [Phase 4]
Summary
Phase 4 trial update for dalfampridine ER in ambulatory activity for people with multiple sclerosis; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brown, Theodore R., M.D., MPH | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2015-04-09